Tolerance and efficacy of targeted therapies prescribed for off-label indications in refractory systemic autoimmune diseases: data of the first 100 patients enrolled in the TATA registry (TArgeted Therapy in Autoimmune Diseases)Jacques‐Eric Gottenberg, Xavier Mariette, Yves Allenbach et al.|RMD Open|2022Cited by 4